RxDoctor Payments Data

Jacques Herzog, MD

Otology & Neurotology · Saint Louis, MONPI 1255330650

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (47.6%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Cochlear Americas accounts for 93.6% of it on its own, with 10 other manufacturers making up the rest. 2025 is the largest year on record at $32,630, 4.1 times the $8,056 reported in 2019.

$62,163in general payments, 2019–2025

Across 135 payments — averaging $460.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cochlear Americas$58K
  • Cochlear Ltd$3K
  • Grace Medical, Inc.$405
  • Med-el Corporation$282
  • Advanced Bionics, LLC$250
  • Medtronic$141
  • plus $417 from 5 others
$501,706in research payments, 2019–2025

Across 85 payments — averaging $5902.42 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Cochlear Americas$502K

What the payments were for

  • Consulting fees$29,60048%
  • Travel & lodging$24,99040%
  • Food & beverage$7,57412%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Cochlear Americas116$58,155
Cochlear Ltd1$2,513
Grace Medical, Inc.3$405
Med-el Corporation3$282
Advanced Bionics, LLC4$250
Medtronic3$141
Iotamotion, Inc.1$138
Stryker1$131
Oticon Medical, LLC1$110
Pfizer1$21
Olympus America Inc.1$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few otology & neurotology providers in Missourito place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$133,585
Medicare patients
345
Services billed
969

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth56$6,278
Ofloxacin103$3,742
Topiramate35$2,791
Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid169$1,401
Mometasone Furoate24$352
Acetazolamide18$338
Meclizine Hcl29$209
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav31$179
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen32$131
Methylprednisolone24$131
Ondansetron OdtOndansetron15$97
Prednisone30$83
Amoxicillin31$68
Diazepam21$33
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim11$29

Paid to pharmacies, not to this prescriber.

Other otology & neurotology in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →